Director, Strategic Alliances & External Engagement – Medical Affairs

Director, Strategic Alliances & External Engagement – Medical Affairs

Join to apply for the Director, Strategic Alliances & External Engagement – Medical Affairs role at Mineralys Therapeutics, Inc.

Mineralys Therapeutics is a clinical‑stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, visit  Follow Mineralys on Linked In, Twitter and Bluesky.

Mineralys is a fully remote company.

The Director of Strategic Alliances & External Engagement is a senior leader within Medical Affairs responsible for developing and executing a cross‑functional coordinated engagement strategy that strengthens Mineralys’ scientific leadership in cardio‑renal‑metabolic disorders. This role drives collaboration across academic institutions, professional societies, patient advocacy organizations, and other key external stakeholders to support the full product lifecycle of lorundrostat, Mineralys’ first‑in‑class aldosterone synthase inhibitor.

By aligning external partnerships with the company’s medical and corporate objectives, this leader ensures that actionable insights, scientific data, and real‑world evidence shape how Mineralys advances its mission to improve outcomes for patients with uncontrolled and resistant hypertension.

• Forge and manage strategic partnerships.
• Identify, evaluate, and cultivate high‑impact relationships with leading academic investigators, clinical networks, professional societies, and patient advocacy groups within the hypertension and broader CRM community.
• Build collaborative frameworks that expand scientific exchange, facilitate data generation, and amplify Mineralys’ visibility in the field.

• Design and implement an integrated engagement roadmap aligned with Medical Affairs pillars, Scientific Communication Platform, and corporate objectives.
• Partner closely with field medical, scientific communications, HEOR, and clinical development teams to ensure coordinated and compliant interactions.
• Lead external collaborations with Key Opinion Leaders (KOLs), digital opinion leaders (DOLs), and academic consortia to deepen understanding of aldosterone‑driven disease mechanisms and treatment paradigms.
• Integrate scientific and clinical insights into medical strategies, field guidance, and future development planning.

• Serve as the Medical Affairs lead for guideline and compendia inclusion strategy, aligning internal evidence generation, publication planning, and external KOL engagement to meet evidence thresholds for consideration.
• Build and sustain strategic alliances with key guideline committees, scientific societies, and evidence‑based medicine organizations to advocate for inclusion of lorundrostat‑related data.

• Design, plan, and execute compliant scientific advisory board meetings (virtual and in‑person) to obtain actionable insights that inform Medical Affairs strategy, evidence generation, and external engagement priorities.
• Identify, recruit, and collaborate with key external experts and thought leaders across hypertension, nephrology, and cardiometabolic specialties to ensure diverse, high‑quality scientific input.
• Develop clear strategic objectives, discussion guides, and post‑meeting analysis to translate insights into tangible actions supporting launch readiness, guideline inclusion, and value communication.
• Partner cross‑functionally with Compliance, Legal, and Commercial stakeholders to ensure all activities align with corporate governance and OIG standards for external scientific interactions.

• Develop and lead the strategic engagement plan with key professional…